These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30775484)

  • 1. Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy.
    Ock SY; Chung YS; Choi YJ
    Osteoporos Sarcopenia; 2016 Sep; 2(3):175-179. PubMed ID: 30775484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.
    Ercolano MA; Drnovsek ML; Silva Croome MC; Moos M; Fuentes AM; Viale F; Feldt-Rasmussen U; Gauna AT
    Thyroid Res; 2013 Sep; 6(1):11. PubMed ID: 24020400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone microarchitecture and bone mineral density in Graves' disease.
    Boro H; Malhotra R; Kubihal S; Khatiwada S; Dogra V; Mannar V; Ahirwar AK; Rastogi V
    Osteoporos Sarcopenia; 2023 Jun; 9(2):70-75. PubMed ID: 37496984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of decreased muscle mass with reduced bone mineral density in patients with Graves' disease.
    Zhang Y; Ke Y; Huang L; Shen X; Yan S; Zhao F; Li Y; Lin Y
    Endocrine; 2022 Mar; 75(3):916-926. PubMed ID: 35064543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.
    Majima T; Komatsu Y; Doi K; Takagi C; Shigemoto M; Fukao A; Morimoto T; Corners J; Nakao K
    Osteoporos Int; 2006; 17(7):1103-10. PubMed ID: 16601919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
    Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Bone Mineral Density at Initial Diagnosis in Children and Adolescents with Graves' Disease.
    Lee HS; Rho JG; Kum CD; Lim JS; Hwang JS
    J Clin Densitom; 2021; 24(2):275-280. PubMed ID: 32546346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.
    Amashukeli M; Korinteli M; Zerekidze T; Jikurauli N; Shanava S; Tsagareli M; Giorgadze E
    J Investig Med; 2013 Jun; 61(5):842-7. PubMed ID: 23612147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism.
    Ugur-Altun B; Altun A; Arikan E; Guldiken S; Tugrul A
    Endocr Res; 2003 Nov; 29(4):389-98. PubMed ID: 14682468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
    Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
    J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
    Sriphrapradang C; Bhasipol A
    Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
    Jódar E; Martínez-Díaz-Guerra G; Azriel S; Hawkins F
    Calcif Tissue Int; 2001 Aug; 69(2):84-7. PubMed ID: 11683428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density.
    Rymuza J; Popow M; Żurecka Z; Przedlacki J; Bednarczuk T; Miśkiewicz P
    Endocrine; 2019 May; 64(2):308-315. PubMed ID: 30506426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
    Al-Bacha S; Lahiri SW
    AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Serum Fractalkine is Associated with Lower Trabecular Bone Score in Premenopausal Women with Graves' Disease.
    Kužma M; Vaňuga P; Binkley N; Ságová I; Pávai D; Blažíček P; Kužmová Z; Jackuliak P; Vaňuga A; Killinger Z; Payer J
    Horm Metab Res; 2018 Aug; 50(8):609-614. PubMed ID: 29954010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
    Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.